Blueberries Medical Corp.
BBRRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.43M
Close$
$-0.01
206.7% downside
Current Fair Value
206.7% downsideOvervalued by 206.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.43 Million |
|---|---|
| Enterprise Value | $7.42 Million |
| Earnings per Share | $0 |
| Beta | 2.65 |
| Outstanding Shares | 495,090,087 |
Return
| Return on Equity | -3706.26% |
|---|---|
| Return on Assets | -158.50% |
| Return on Invested Capital | -2583.82% |
Valuation & Multiples
| P/E Ratio | -7.14 |
|---|---|
| PEG | -325.49 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 26.78 |
| Enterprise Value to EBIT | -10.02 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 31, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 30, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Blueberries Medical Corp.
51 employees
CEO: Facundo Garreton
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade...